Screening for elevated albuminuria and subsequently hypertension identifies subjects in which treatment may be warranted to prevent renal function decline
Autor: | Stephan J. L. Bakker, Sipke T. Visser, Paul E. de Jong, Chris H. L. Thio, Akin Ozyilmaz, Ron T. Gansevoort |
---|---|
Přispěvatelé: | Groningen Institute for Organ Transplantation (GIOT), Lifestyle Medicine (LM), Groningen Kidney Center (GKC), PharmacoTherapy, -Epidemiology and -Economics, Cardiovascular Centre (CVC) |
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Male
030232 urology & nephrology detection Blood Pressure PROGRESSION 030204 cardiovascular system & hematology GLOMERULAR-FILTRATION-RATE DISEASE 0302 clinical medicine Risk Factors Prevalence Prospective Studies Renal Insufficiency Prospective cohort study Morning GENERAL-POPULATION ACE-INHIBITION RISK education.field_of_study Middle Aged Nephrology Disease Progression Female medicine.symptom Cohort study Glomerular Filtration Rate Adult medicine.medical_specialty hypertension Population Urology Renal function Sensitivity and Specificity albuminuria DIETARY-PROTEIN RESTRICTION 03 medical and health sciences Internal medicine medicine Humans STRATEGY education CARDIOVASCULAR EVENTS METAANALYSIS Aged Transplantation kidney function decline business.industry screening Confidence interval Endocrinology Blood pressure Albuminuria business |
Zdroj: | Nephrology, Dialysis, Transplantation, 32(2), 200-208. Oxford University Press |
ISSN: | 1460-2385 0931-0509 |
Popis: | Background. We investigated whether initial population screening for elevated albuminuria with subsequent screening for hypertension in case albuminuria is elevated may be of help to identify subjects at risk for accelerated decline in kidney function.Methods. We included subjects who participate in the PREVEND observational, general population-based cohort study and had two or more glomerular filtration rate (eGFR) measurements available during follow-up. Elevated albuminuria was defined as an albumin concentration >= 20 mg/L in a first morning urine sample confirmed by an albumin excretion >= 30mg/day in two 24-h urines. Hypertension was defined as systolic blood pressure >= 140mmHg, diastolic blood pressure >= 90mmHg or use of blood pressure-lowering drugs. eGFR was estimated with the CKD-EPI creatinine-cystatin C equation.Results. Overall, 6471 subjects were included with a median of 4 [95% confidence interval (CI) 2-5] eGFR measurements during a follow-up of 11.3 (95% CI 4.0-13.7) years. Decline in eGFR was greater in the subgroups with elevated albuminuria. This held true, not only in subjects with known hypertension (-1.84+/-2.27 versus -1.16+/-1.45mL/min/1.73m(2) per year, P= 55 years of age andmale subjects. In addition, subjects with elevated albuminuria had higher blood pressure than subjects with normoalbuminuria, and in subjects with elevated albuminuria as yet undiagnosed hypertension was twice as prevalent as diagnosed hypertension.Conclusions. Initial screening for elevated albuminuria followed by screening for hypertension may help to detect subjects with increased risk for a steeper decline in kidney function. |
Databáze: | OpenAIRE |
Externí odkaz: |